-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Assembly Biosciences, Inc. annual/quarterly Net Cash Provided by (Used in) Operating Activities history and growth rate from 2010 to 2024.
- Assembly Biosciences, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$18.4M, a 21.6% increase year-over-year.
- Assembly Biosciences, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$51.1M, a 325% decline from 2023.
- Assembly Biosciences, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was $22.7M.
- Assembly Biosciences, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$84.5M, a 9.57% increase from 2021.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)